PFIZER INC - 31 Dec 2024 SCHEDULE 13G/A Report for Cardiff Oncology, Inc. Common Stock, $0.0001 par value per share (CRDF)

Filing Manager
PFIZER INC
Reporting Manager
Pfizer Inc. 13-5315170
Security
Cardiff Oncology, Inc. Common Stock, $0.0001 par value per share
Symbol
CRDF
Shares outstanding
66,988,194 shares
Disclosed Ownership
2,411,575 shares
Ownership
3.6%
Form type
SCHEDULE 13G/A
Filing time
12 Feb 2025, 14:48:08 UTC
Date of event
31 Dec 2024
SEC
View on sec.gov

Quoteable Key Fact

"PFIZER INC disclosed 3.6% ownership in Cardiff Oncology, Inc. Common Stock, $0.0001 par value per share (CRDF) on 31 Dec 2024."

Quick Takeaways

  • PFIZER INC filed SCHEDULE 13G/A for Cardiff Oncology, Inc. Common Stock, $0.0001 par value per share (CRDF).
  • Disclosed ownership: 3.6%.
  • Date of event: 31 Dec 2024.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 12 Feb 2025, 14:48.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Pfizer Inc. 13-5315170 3.6% 2,411,575 2,411,575 0 /s/ Madelyn D. Purcell Madelyn D. Purcell/Assistant Secretary
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .